Molecular subtyping improves diagnostic stratification of patients with primary breast cancer into prognostically defined risk groups.
Molecular subtyping improves diagnostic stratification of patients with primary breast cancer into prognostically defined risk groups. Breast Cancer Res Treat. 2015 Nov; 154(1):81-8.